Seniors waiting for Trump’s $200 debit card may not get the prescription help they hope for

Seniors waiting for Trump’s $200 debit card may not get the prescription help they hope for

by Harris Meyer, Kaiser Health News
“A $200 card is better than a sharp stick in the eye, but it won’t be that meaningful,” said Tom Scully, the Medicare chief under President George W. Bush.
Meet the man selling marijuana across from Trenton’s City Hall. Even the mayor is a fan of ‘NJWeedman.’

‘The best thing to ever happen to Trenton’: NJWeedman dares police to bust his illegal pot shop. Here’s why.

by Sam Wood
For nearly two decades, Ed Forchion has pursued a quixotic effort to legalize marijuana in New Jersey. He wants current underground dealers to have a chance to cash in.
Meet the man selling marijuana across from Trenton’s City Hall. Even the mayor is a fan of ‘NJWeedman.’

‘The best thing to ever happen to Trenton’: NJWeedman dares police to bust his illegal pot shop. Here’s why.

For nearly two decades, Ed Forchion has pursued a quixotic effort to legalize marijuana in New Jersey. He wants current underground dealers to have a chance to cash in.
Head of vaccination effort says the J&J and AstraZeneca trials might resume this week

Head of vaccination effort says the J&J and AstraZeneca trials might resume this week

by Cynthia Koons and Stephanie Baker, Bloomberg
The two companies developing COVID-19 vaccines backed by Operation Warp Speed temporarily halted their trials because participants fell ill, slowing the race for a shot to halt the pandemic.
Head of vaccination effort says the J&J and AstraZeneca trials might resume this week

Head of vaccination effort says the J&J and AstraZeneca trials might resume this week

by Cynthia Koons and Stephanie Baker, Bloomberg
The two companies developing COVID-19 vaccines backed by Operation Warp Speed temporarily halted their trials because participants fell ill, slowing the race for a shot to halt the pandemic.
OxyContin maker Purdue Pharma to plead guilty to three criminal charges

OxyContin maker Purdue Pharma to plead guilty to three criminal charges

by Michael Balsamo and Geoff Mulvihill, Associated Press
The federal counts include conspiracy to defraud the United States and violating federal anti-kickback laws, officials said.
OxyContin maker Purdue Pharma to plead guilty to three criminal charges

OxyContin maker Purdue Pharma to plead guilty to three criminal charges

by Michael Balsamo and Geoff Mulvihill, Associated Press
The federal counts include conspiracy to defraud the United States and violating federal anti-kickback laws, officials said.
More Stories
What happens if New Jersey legalizes marijuana? Everything you need to know.

What happens if New Jersey legalizes marijuana? Everything you need to know.

by Sam Wood
How soon and where will it be sold? Will Pennsylvanians be able to buy weed in N.J.?
A cellulite-fighting drug is a big part of Malvern-based Endo’s plan to buy BioSpecifics for $658 million
Column

A cellulite-fighting drug is a big part of Malvern-based Endo’s plan to buy BioSpecifics for $658 million

by Joseph N. DiStefano
Endo is paying a record price for BioSpecifics, a longtime supplier. And Endo shares rose on word of the deal.
Why some Pa. marijuana patients face jail for not surrendering their medical marijuana cards

Why some Pa. marijuana patients face jail for not surrendering their medical marijuana cards

by Sam Wood
The ACLU and critics says some judges are wrongly blocking holders of medical marijuana carts from drug court programs.
Philly-based GoPuff, the Wawa on wheels, raises $380 million more, says it’s worth nearly $4 billion
Column

Philly-based GoPuff, the Wawa on wheels, raises $380 million more, says it’s worth nearly $4 billion

by Joseph N. DiStefano
GoPuff, the Philly-based delivery service, raises another fortune, this time from Silicon Valley, making it a rare “unicorn" among Philadelphia-area start-ups.
Immunome IPO on target as investors bet big on gene, cell therapies

Immunome IPO on target as investors bet big on gene, cell therapies

by Joseph N. DiStefano
Immunome is the latest pre-product, pre-profit biotech to go public with an IPO.
Moderna’s coronavirus vaccine won’t be ready for the public until the spring, its CEO says

Moderna’s coronavirus vaccine won’t be ready for the public until the spring, its CEO says

by Paulina Firozi, Washington Post
Three other vaccine candidates are in the final stages of testing in the United States, though one of them has been paused.
Radnor firm — with a product heroin makers rely on — stops key sales in Mexico
Column

Radnor firm — with a product heroin makers rely on — stops key sales in Mexico

by Joseph N. DiStefano
The Main Line-based based company started by ex-Rohm and Haas boss and corporate-governance thinker Rajiv L. Gupta, was a favored, if inadvertent, chemical supplier to Mexico's illegal heroin labs
AstraZeneca’s setback delivers reality check on vaccine risks

AstraZeneca’s setback delivers reality check on vaccine risks

by Lisa Du, Bloomberg
One of the most promising coronavirus vaccines has stumbled, delivering a reality check about the odds of clinical development and the safety risks involved.
Rather than give away its COVID-19 vaccine, Oxford makes a deal with drugmaker

Rather than give away its COVID-19 vaccine, Oxford makes a deal with drugmaker

by Jay Hancock, Kaiser Health News
In the U.S. and other developed nations, the solution to the reluctance of drug companies to create vaccines was to shower them with billions of dollars in public funds to persuade them to help.
New to medical marijuana? Curious? Here’s what experts say you should know.

New to medical marijuana? Curious? Here’s what experts say you should know.

by Sam Wood
Too much of a good thing can lead to serious confusion — and we're not just talking dosage. The number of product choices in Pennsylvania dispensaries can be overwhelming. Here's how to start.
FSD Pharma’s medical marijuana dreams go up in smoke

FSD Pharma’s medical marijuana dreams go up in smoke

by Sam Wood
The company will focus on an anti-inflammatory drug its CEO said will treat COVID-19 patients.
FDA calls for removal of fruity, disposable e-cigarettes

FDA calls for removal of fruity, disposable e-cigarettes

by Matthew Perrone, Associated Press
U.S. health officials are cracking down on fruity disposable electronic cigarettes that are popular with teenagers.
FDA grants emergency approval to Quest COVID-19 test for ‘pooled’ sample use

FDA grants emergency approval to Quest COVID-19 test for ‘pooled’ sample use

by The Associated Press
The Food and Drug Administration has given emergency approval to Quest Diagnostics to use a new approach to coronavirus testing that combines test samples in batches instead of running them one by one, speeding up the process. It is the first test to be authorized to be used in this way.
SPECIAL REPORTS
Investigative reports, featured series, and guides to living in the Philadelphia region, brought to you by The Inquirer.
READ MORE
WHAT ARE YOU CURIOUS ABOUT?
Send us your burning questions, or vote on other readers' questions that pique your interest. Our journalists will work to answer them.
ASK US